Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Deals
Shenzhen TargetRx Raises Hundreds of Millions in Series B Financing for Drug Development
March 2, 2025
Drug
Ascletis Pharma Files IND Application for ASC10 with US FDA
March 2, 2025
Company
Drug
MabPharm’s CMAB017 Receives NMPA Approval for Clinical Study in Solid Tumors
March 2, 2025
Company
Deals
Zhejiang Medicine’s NovoCodex Subsidiary Receives RMB 402M Investment
March 2, 2025
Company
Deals
Medicilon Biomedical Plans RMB 2.16B Private Placement for R&D Expansion
March 2, 2025
Company
Drug
Hansoh Pharmaceutical’s Generic Ibrance Approved by NMPA
March 2, 2025
Company
Digital
Alibaba Health’s 2022 Financial Report Shows Revenue Growth, Net Loss
March 2, 2025
Company
Policy / Regulatory
Wuxi Biologics Set to Be Removed from US Restricted Trade List
March 2, 2025
Policy / Regulatory
R&D
CDE Releases 60th Batch of Chemical Generic Reference Preparations
March 2, 2025
Company
Deals
Beijing Tianshi Tongda Raises RMB 140M for Autoimmune Disease Therapies
March 3, 2025
Company
Deals
Wuhan YZY Biopharma Raises RMB 200M for Bispecific Antibodies and COVID-19 Vaccine Development
March 2, 2025
Company
Deals
Shandong Xinhua Pharmaceutical Inks Tech Transfer Deal for LXH-2201 with IMM
March 2, 2025
1
2
…
1,179
1,180
1,181
1,182
1,183
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?